Mycophenolate Mofetil is also known as MYCOPHENOLATE MOFETIL. The drug is prepared in the form of capsules with a weight of 250mg. This medication comes in the form of an oblong, caramel-blue capsule, printed with the words "54 848" and "54 848". The drug has an immunosuppressive effect, often used in patients who have recently received new organ transplants.

Diarrhea and other gastrointestinal symptoms are common complications after solid organ transplantation, with an incidence of 12.6%, and up to 34% of cases may be related to the use of immunosuppressive drugs. The inclusion of MMF (Mycophenolate mofetil) in the immunosuppressive regimen has significantly reduced the rate of acute rejection, although its use is associated with an increased rate of gastrointestinal complications.

The pathogenesis of inflammatory bowel disease centers on dysregulated immunity. It is therefore not surprising that drugs that alter host immunity can sometimes lead to the development of new-onset inflammatory bowel disease, which the authors refer to as “drug-induced secondary inflammatory bowel disease.”